Target Name: ZNF136
NCBI ID: G7695
Other Name(s): ZNF136 variant 1 | Zinc finger protein 136 (isoform 1) | PHZ-20 | zinc finger protein 136 | ZN136_HUMAN | Zinc finger protein 136, transcript variant 1 | pHZ-20 | Zinc finger protein 136

ZNF136: A Potential Drug Target Or Biomarker for Various Diseases

ZNF136 (ZNF136 variant 1) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. ZNF136 is a non-coding RNA molecule that is part of the ZNF gene family, which is known for its role in regulating gene expression and cell development.

The ZNF136 gene has been shown to play a role in the development and progression of various diseases, including cancer. For example, studies have shown that high levels of ZNF136 are associated with poor prognosis in cancer patients. Additionally, ZNF136 has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its potential role in disease, ZNF136 has also been identified as a potential drug target. Researchers have shown that inhibiting the activity of ZNF136 can lead to the downregulation of genes involved in cancer progression and the regression of neurodegenerative diseases. Additionally, studies have shown that blocking the function of ZNF136 can also lead to the inhibition of cellular processes that are involved in the development of certain diseases, such as the regulation of cell death.

Another potential application of ZNF136 as a drug target is its potential role as a biomarker. Researchers have shown that the levels of ZNF136 in certain tissues, such as the brain, have been associated with the development of certain diseases, such as cancer and neurodegenerative diseases. Additionally, studies have shown that the levels of ZNF136 in certain biological samples, such as blood or urine, can also be used as a biomarker for disease.

Overall, ZNF136 is a gene that has the potential to be a drug target or biomarker for the treatment of various diseases. Further research is needed to fully understand its role and to develop effective treatments for the associated conditions.

Protein Name: Zinc Finger Protein 136

Functions: May be involved in transcriptional regulation as a weak repressor when alone, or a potent one when fused with a heterologous protein containing a KRAB B-domain

More Common Targets

ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257 | ZNF26 | ZNF260 | ZNF263 | ZNF264 | ZNF266 | ZNF267 | ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282